SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-250724
Filing Date
2023-10-04
Accepted
2023-10-04 16:05:52
Documents
15
Period of Report
2023-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d541910d8k.htm   iXBRL 8-K 27513
2 EX-99.1 d541910dex991.htm EX-99.1 22539
6 GRAPHIC g541910g1003205904794.jpg GRAPHIC 3397
7 GRAPHIC g541910newpage1.jpg GRAPHIC 11808
  Complete submission text file 0001193125-23-250724.txt   200521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20231004.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20231004_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20231004_pre.xml EX-101.PRE 11710
9 EXTRACTED XBRL INSTANCE DOCUMENT d541910d8k_htm.xml XML 3469
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 231307936
SIC: 2834 Pharmaceutical Preparations